Are Options Traders Betting on a Big Move in Pacira BioSciences (PCRX) Stock?
Press Release: Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer
Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Fly 27% But Investors Aren't Buying For Growth
The Three-year Loss for Pacira BioSciences (NASDAQ:PCRX) Shareholders Likely Driven by Its Shrinking Earnings
RBC Capital Maintains Sector Perform on Pacira BioSciences, Raises Price Target to $15
Does Pacira BioSciences (NASDAQ:PCRX) Have A Healthy Balance Sheet?